HGS v. Eli Lilly, UK Supreme Court, 2 November 2011
January 1, 2012
The UK Supreme Court overturned the decision of the High Court and the Court of Appeal that HGS's patent directed towards Neutrokine, a new protein and member of the ligand superfamily, lacked industrial applicability.
Click here for the full text of this case. A summary of this case will be posted on http://www.KluwerIPCases.com.
Comments (0)
Your email address will not be published.
Become a contributor!
Interested in contributing? Submit your proposal for a blog post now and become a part of our legal community!
Contact Editorial Guidelines
